Skip to main content
Caplight Logo









Bioeutectics

Bioeutectics

Private
Tulsa, OklahomaEnergy & Sustainabilityhttps://www.bioeutectics.com/

Last Round

Seed

Jan 23, 2024

Total Funding Raised

$2.82M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Bioeutectics is a biotechnology company developing natural and sustainable eutectic solvents to replace petrochemicals in industrial processes.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Biotechnology, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

natural deep eutectic solventsNADESgreen chemistrybio-based solventssustainable ingredientssolvent replacementclean labelcustom formulationbiotechnologyAI-driven discoverymolecular designbiodegradable solventsagrotech ingredientscosmetic ingredientsindustrial extraction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioeutectics Comparables

Compare Bioeutectics with similar companies based on industry and business-model similarity.

Bioeutectics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NADES Design
79%
Minasolve LLC
77%
Shrieve Chemical Company
73%

Bioeutectics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 23, 2024
Pre SeedDec 22, 2022

Key People

Founding team and executive leadership

Federico JV Gomez

CTO And Co-founder, Chief Technology Officer

Founding Team

Maria Fernanda Silva

Co-Founder And Chief Scientific Officer At Bioeutectics

Founding Team

Bioeutectics Investors

Notable investors and investment history

Bioeutectics investors
InvestorRounds
GRIDXSeed, Pre Seed
Fen VenturesSeed
IndieBioSeed
Atento CapitalSeed
Syensqo VenturesSeed
SOSVSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Grew 21% QoQ, from 14 to 17 employees.

  • Aug 2, 2026

    Grew 29% QoQ from 14 to 18 employees.

Bioeutectics Filings

Explore SEC and related filing metadata, where available.

Bioeutectics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bioeutectics's valuation, stock price, and market status.

Is Bioeutectics a public or private company?

Bioeutectics is a private company.

What is the current stock price of Bioeutectics?

Bioeutectics is a private company with no public stock price. No recent secondary market data is available.

How much is Bioeutectics worth (valuation)?

Valuation information for Bioeutectics is not publicly available.

Can I buy Bioeutectics stock?

Bioeutectics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bioeutectics's last funding round?

Bioeutectics's most recent funding round was Seed on January 23, 2024.

Who are the main investors in Bioeutectics?

Key investors in Bioeutectics include Fen Ventures, Atento Capital.

Will Bioeutectics IPO soon?

No public IPO plans have been announced for Bioeutectics.

How can I track Bioeutectics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bioeutectics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTulsa, Oklahoma
Employee Range15
Year Founded2020
Last FundingJan 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?